November 2024 Vol 15, No 11

The term “lay navigator” is derogatory toward the patient navigators who have training in an oncology health–related field and who are recognized by the Centers for Medicare & Medicaid Services as professionals entitled to reimbursement for their specialized services.

Researchers share findings from a study on the creation and early use of the Zone Tool for Oncology, a geriatric-friendly, single-page, color-coded symptom self-assessment tool for patients undergoing anticancer treatment.

In this fourth installment of a 5-part series, the authors provide tools for navigators to effectively guide patients through the clinical trial experience, with a focus on molecular profiling and genetic testing.

Durvalumab consolidation therapy improved overall and progression-free survival in patients with limited-stage small cell lung cancer that did not progress after standard-of-care concurrent chemoradiotherapy.

Explore curated coverage of select research presented at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer.

The November 2024 CATCH is awarded to Sherry Reji, Oncology Nurse Navigator With MD Anderson Cancer Center.

A cancer diagnosis can have a critical impact on sexual health. It is therefore crucial that sexual health be routinely addressed to mitigate distress, enhance patient care, and improve quality of life.